天坛生物下属企业人凝血酶原复合物完成Ⅲ期临床试验

Core Viewpoint - Tian Tan Biological announced the completion of Phase III clinical trials for its "Prothrombin Complex Concentrate," which shows significant efficacy in treating hemophilia B and related coagulation disorders [1] Group 1: Clinical Trial Results - The Prothrombin Complex Concentrate is designed to treat congenital and acquired deficiencies of coagulation factors II, VII, IX, and X, including hemophilia B, anticoagulant overdose, and vitamin K deficiency [1] - Clinical trial results indicate that the infusion of this product significantly increases the levels of coagulation factors II, VII, IX, and X in hemophilia B patients, thereby improving their coagulation function and alleviating bleeding symptoms [1]